In Vitro Effects of Budesonide on Eosinophil-basophil Lineage Commitment
Overview
Authors
Affiliations
Unlabelled: IL-5 is the primary cytokine that stimulates the production and survival of eosinophils and basophils from progenitor cells. The inhaled glucocorticoid, budesonide, has been shown to exert a therapeutic effect via suppression of eosinophil/basophil progenitors in vivo. Since various steroids have exhibited the ability to enhance eosinophil/basophil progenitor differentiation, we examined the effects of budesonide in vitro. Bone marrow and cord blood samples were obtained and cultured in the presence of IL-5 alone or IL-5 plus budesonide. Eosinophil/basophil colony-forming units were enumerated from cultured nonadherent mononuclear cells and from purified CD34⁺ cells. CD34⁺ cells with and without budesonide were also examined for up-regulation of ERK1/2, MAPK and GATA-1 using real time-PCR.
Results: i) up-regulation of eosinophil/basophil colony-forming units is due to the direct effects of budesonide on IL-5-stimulated progenitors; ii) GATA-1 is likely involved in the early amplification of eosinophil/basophil progenitor commitment leading to increased differentiation. A potential transcriptional pathway has been identified which may mediate the effects of budesonide on eosinophil/basophil lineage commitment.
Xavier-Elsas P, Masid-de-Brito D, Vieira B, Ignez C Gaspar-Elsas M World J Exp Med. 2017; 7(1):11-24.
PMID: 28261551 PMC: 5316900. DOI: 10.5493/wjem.v7.i1.11.
Panousis C, Dhagat U, Edwards K, Rayzman V, Hardy M, Braley H MAbs. 2015; 8(3):436-53.
PMID: 26651396 PMC: 4966837. DOI: 10.1080/19420862.2015.1119352.
Xavier-Elsas P, da Silva C, Vieira B, Masid-de-Brito D, Queto T, de Luca B Mediators Inflamm. 2015; 2015:495430.
PMID: 26063973 PMC: 4434200. DOI: 10.1155/2015/495430.
Smith S, Hill M, Oliveria J, Watson B, Baatjes A, Dua B Immunology. 2014; 142(3):484-91.
PMID: 24628018 PMC: 4080964. DOI: 10.1111/imm.12280.
Ellis A, Ackerman S, Crawford L, Du J, Bedi R, Denburg J Pediatr Allergy Immunol. 2010; 21(4 Pt 1):640-8.
PMID: 20337967 PMC: 10411049. DOI: 10.1111/j.1399-3038.2010.01003.x.